NCCN Imaging Appropriate Use Criteria to Be Integrated Into National Decision Support Company’s CareSelect Imaging
Integration of NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) into NDSC CareSelect Imaging will provide access to evidence-based imaging recommendations adapted from the NCCN Guidelines®.
25-Jul-2016 10:30 AM EDT Add to Favorites
Older Women in the United States Not Receiving Recommended Bone Density Testing Before Starting Cancer Treatment, Study Finds
A Medical College of Wisconsin study published in the July issue of JNCCN found that older women are not receiving recommended bone density assessment prior to adjuvant therapy with aromatase inhibitors, possibly making them more vulnerable to bone...
13-Jul-2016 12:00 PM EDT Add to Favorites
NCCN Accepted as CMS-Approved Provider-Led Entity for Development of Imaging Appropriate Use Criteria
NCCN joins 10 other multidisciplinary organizations as a qualified provider-led entity under the Medicare Appropriate Use Criteria (AUC) program for advanced diagnostic imaging.
11-Jul-2016 11:00 AM EDT Add to Favorites
New NCCN Guidelines for Patients® and NCCN Quick Guide™ series outline disease basics, testing, and treatment information about MDS so patients can make well-informed decisions about their cancer care.
28-Jun-2016 1:00 PM EDT Add to Favorites
NCCN Policy Summit to Address the State of HIT June 27 in Washington, D.C.
13-Jun-2016 10:40 AM EDT Add to Favorites
New NCCN Guidelines for Patients® and NCCN Quick Guide™ outline disease basics, testing, and treatment information about Mycosis Fungoides so patients can make well-informed decisions about their cancer care.
10-Jun-2016 3:30 PM EDT Add to Favorites
High-Quality Management of Physical and Depressive Symptoms May Reduce Severe Anxiety at End of Life for Patients with Cancer, Study Finds
A new study published today on JNCCN.org suggests that severe anxiety at end of life in patients with cancer is caused not solely by proximity to death, but by disease burden and psychosocial issues.
10-Jun-2016 8:35 AM EDT Add to Favorites
NCCN Awards Research Grants to Eight Investigators to Support Clinical and Pre-Clinical Studies of Mirvetuximab Soravtansine in Various Cancers
The NCCN Oncology Research Program has awarded research grants to eight investigators to study the effectiveness of mirvetuximab soravtansine in folate receptor alpha-positive cancers.
6-Jun-2016 2:30 PM EDT Add to Favorites